{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T16:20:13Z","timestamp":1794932413697,"version":"4.9.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.vaccine.2026.129096","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T21:02:37Z","timestamp":1787950957000},"page":"129096","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Effectiveness of COVID-19 vaccination schedules against severe COVID-19 in children aged 6\u00a0months to 4\u00a0years in Brazil: A population-based cohort study (2023\u20132024)"],"prefix":"10.1016","volume":"91","author":[{"given":"Isaac Negretto","family":"Schrarstzhaupt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredi Alexander","family":"Diaz-Quijano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.129096_bb0005","doi-asserted-by":"crossref","DOI":"10.33448\/rsd-v11i11.33041","article-title":"A evolu\u00e7\u00e3o das coberturas vacinais brasileiras e os impactos provocados pela pandemia de Covid-19 nas metas de imuniza\u00e7\u00e3o","volume":"11","author":"Leite","year":"2022","journal-title":"Res Soc Dev"},{"key":"10.1016\/j.vaccine.2026.129096_bb0010","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.jped.2022.11.004","article-title":"Vaccination coverage in children in the period before and during the COVID-19 pandemic in Brazil: a time series analysis and literature review","volume":"99","author":"Domingues","year":"2023","journal-title":"J Pediatr (Rio J)"},{"key":"10.1016\/j.vaccine.2026.129096_bb0015","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1590\/1413-81232022273.20082021","article-title":"Impact of the COVID-19 pandemic on the vaccination of children 12 months of age and under: an ecological study","volume":"27","author":"Procianoy","year":"2022","journal-title":"Cienc Saude Coletiva"},{"key":"10.1016\/j.vaccine.2026.129096_bb0020","doi-asserted-by":"crossref","first-page":"115","DOI":"10.11606\/s1518-8787.2020054003142","article-title":"Pandemia e coberturas vacinais: desafios para o retorno \u00e0s escolas","volume":"54","author":"Sato","year":"2020","journal-title":"Rev Sa\u00fade P\u00fablica"},{"key":"10.1016\/j.vaccine.2026.129096_bb0025","doi-asserted-by":"crossref","DOI":"10.1590\/s1678-9946202365011","article-title":"Hospitalizations and deaths of children and adolescents with severe acute respiratory infection due to COVID-19 during the epidemiological year of 2020","volume":"65","author":"Soares","year":"2023","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.vaccine.2026.129096_bb0030","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12929-022-00853-8","article-title":"COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection","volume":"29","author":"Chi","year":"2022","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.vaccine.2026.129096_bb0035","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa2119451","article-title":"Covid-19 vaccine effectiveness against the omicron (B.1.1.529) variant","volume":"386","author":"Andrews","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2026.129096_bb0040","first-page":"2584","article-title":"Evaluation of vaccine effectiveness of mRNA COVID-19 vaccines in children: a systematic review and meta-analysis","volume":"28","author":"Hu","year":"2024","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.vaccine.2026.129096_bb0045","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/cid\/ciaa1425","article-title":"Warp speed for coronavirus disease 2019 (COVID-19) vaccines: why are children stuck in neutral?","volume":"73","author":"Anderson","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2026.129096_bb0050","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJMoa2211031","article-title":"Evaluation of BNT162b2 Covid-19 vaccine in children younger than 5 years of age","volume":"388","author":"Mu\u00f1oz","year":"2023","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.vaccine.2026.129096_bb0055","doi-asserted-by":"crossref","first-page":"36638","DOI":"10.1038\/s41598-025-20483-y","article-title":"Clinical manifestations and severity of COVID-19 caused by omicron among paediatric patients aged 0\u201317 years in Italy","volume":"15","author":"Scutari","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2026.129096_bb0060","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jinf.2020.10.033","article-title":"First and second COVID-19 waves in Japan: a comparison of disease severity and characteristics","volume":"82","author":"Saito","year":"2021","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2026.129096_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/epidemiologia6030040","article-title":"A series of severe and critical COVID-19 cases in hospitalized, unvaccinated children: clinical findings and hospital care","volume":"6","author":"da Costa","year":"2025","journal-title":"Epidemiol"},{"key":"10.1016\/j.vaccine.2026.129096_bb0070","series-title":"NOTA T\u00c9CNICA No 399\/2022-CGPNI\/DEIDT\/SVS\/MS - Recomenda\u00e7\u00e3o da vacina COVID-19 Pfizer-BioNTech para crian\u00e7as de 6 meses a 4 anos de idade (4 anos, 11 meses e 29 dias)","author":"Minist\u00e9rio da Sa\u00fade, Brasil","year":"2022"},{"key":"10.1016\/j.vaccine.2026.129096_bb0075","series-title":"NOTA T\u00c9CNICA No 213\/2022-CGPNI\/DEIDT\/SVS\/MS","author":"Minist\u00e9rio da Sa\u00fade, Brasil","year":"2022"},{"key":"10.1016\/j.vaccine.2026.129096_bb0080","author":"Vacinometro COVID-19"},{"key":"10.1016\/j.vaccine.2026.129096_bb0085","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/s41591-022-01874-4","article-title":"Effectiveness of CoronaVac in children 3\u20135 years of age during the SARS-CoV-2 omicron outbreak in Chile","volume":"28","author":"Jara","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2026.129096_bb0090","article-title":"COVID-19 vaccines versus pediatric hospitalization","volume":"4","author":"Rosa Duque","year":"2023","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.vaccine.2026.129096_bb0100","article-title":"CDC Acts on presidential memorandum to update childhood immunization schedule","author":"CDC","year":"2026","journal-title":"CDC Newsroom"},{"key":"10.1016\/j.vaccine.2026.129096_bb0110","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0140-6736(22)01245-4","article-title":"COVID-19 vaccination for children aged 5\u201311 years","volume":"400","author":"Ladhani","year":"2022","journal-title":"The Lancet"},{"key":"10.1016\/j.vaccine.2026.129096_bb0115","author":"Brasil"},{"key":"10.1016\/j.vaccine.2026.129096_bb0120","author":"Brasil"},{"key":"10.1016\/j.vaccine.2026.129096_bb0130","series-title":"Sa\u00fade mais perto de voc\u00ea: acesso e qualidade: programa nacional de melhoria do acesso e da qualidade da aten\u00e7\u00e3o b\u00e1sica (PMAQ): manual instrutivo. Ms","author":"Brasil","year":"2012"},{"key":"10.1016\/j.vaccine.2026.129096_bb0135","author":"Brasil"},{"key":"10.1016\/j.vaccine.2026.129096_bb0140","author":"Minist\u00e9rio da Sa\u00fade, Brasil"},{"key":"10.1016\/j.vaccine.2026.129096_bb0145","author":"Minist\u00e9rio da Sa\u00fade, Brasil"},{"key":"10.1016\/j.vaccine.2026.129096_bb0150","author":"Minist\u00e9rio da Sa\u00fade"},{"key":"10.1016\/j.vaccine.2026.129096_bb0155","doi-asserted-by":"crossref","DOI":"10.1017\/dap.2024.70","article-title":"AI innovation in healthcare and state platforms under a rights-based perspective: the case of Brazillian RNDS","volume":"6","author":"Falc\u00e3o","year":"2024","journal-title":"Data & Policy"},{"key":"10.1016\/j.vaccine.2026.129096_bb0165","author":"Firely"},{"key":"10.1016\/j.vaccine.2026.129096_bb0170","article-title":"Effectiveness of mass dengue vaccination with CYD-TDV (Dengvaxia\u00ae) in the state of Paran\u00e1, Brazil: integrating case-cohort and case-control designs","volume":"35","author":"Diaz-Quijano","year":"2024","journal-title":"Lancet Reg Health Am"},{"key":"10.1016\/j.vaccine.2026.129096_bb0175","author":"Minist\u00e9rio da Sa\u00fade, Brasil"},{"key":"10.1016\/j.vaccine.2026.129096_bb0180","author":"Minist\u00e9rio da Sa\u00fade, Brasil"},{"key":"10.1016\/j.vaccine.2026.129096_bb0185","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1001\/jamapediatrics.2023.4505","article-title":"Effectiveness of monovalent mRNA vaccines against Omicron XBB infection in Singaporean children younger than 5 years","volume":"177","author":"Wee","year":"2023","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.vaccine.2026.129096_bb0190","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm7104e2","article-title":"COVID-19 incidence and death rates among unvaccinated and fully vaccinated adults with and without booster doses during periods of Delta and Omicron variant emergence \u2014 25 U.S. jurisdictions, April 4\u2013December 25, 2021","volume":"71","author":"Johnson","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2026.129096_bb0195","article-title":"Monitoring incidence of COVID-19 cases, hospitalizations, and deaths, by vaccination status \u2014 13 U.S. jurisdictions, April 4\u2013July 17, 2021","volume":"70","author":"Heather","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2026.129096_bb0200","doi-asserted-by":"crossref","first-page":"606","DOI":"10.15585\/mmwr.mm7117e3","article-title":"Seroprevalence of infection-induced SARS-CoV-2 antibodies - United States, September 2021-February 2022","volume":"71","author":"Clarke","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2026.129096_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101786","article-title":"SARS-CoV-2 seroprevalence in children worldwide: a systematic review and meta-analysis","volume":"56","author":"Naeimi","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.vaccine.2026.129096_bb0210","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.puhe.2023.10.010","article-title":"High prevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) antibodies among unvaccinated children of Chandigarh, Northwest India, in a household-based paediatric serosurvey post-second wave of pandemic (June to July 2021)","volume":"225","author":"Ghosh","year":"2023","journal-title":"Public Health"},{"key":"10.1016\/j.vaccine.2026.129096_bb0215","doi-asserted-by":"crossref","first-page":"i31","DOI":"10.1093\/ije\/dyaf143","article-title":"A countrywide study on post-COVID-19 condition in Brazil: the Epicovid 2.0","volume":"55","author":"Wehrmeister","year":"2025","journal-title":"Int J Epidemiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26009059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26009059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T15:49:08Z","timestamp":1794930548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26009059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":39,"alternative-id":["S0264410X26009059"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129096","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of COVID-19 vaccination schedules against severe COVID-19 in children aged 6\u00a0months to 4\u00a0years in Brazil: A population-based cohort study (2023\u20132024)","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129096","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"129096"}}